IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1
暂无分享,去创建一个
C. Gravel | J. Kriz | R. Rahimian | G. Soucy | E. Abdelhamid | Louis-Charles Béland | M. Gravel | Essam Abdelhamid | Mathieu Gravel | Louis-Charles Béland | Geneviève Soucy | Reza Rahimian
[1] Nathan D. Price,et al. IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior , 2015, Neuron.
[2] M. Guillot-Sestier,et al. Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology , 2015, Neuron.
[3] J. Julien,et al. Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis , 2014, Neurotherapeutics.
[4] A. Członkowska,et al. The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson’s disease , 2014, Pharmacological reports : PR.
[5] D. Hafler,et al. Regulatory T cells in autoimmune neuroinflammation , 2014, Immunological reviews.
[6] P. Popovich,et al. Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis , 2014, Neuron.
[7] A. Hill,et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms , 2014, Proceedings of the National Academy of Sciences.
[8] J. Connor,et al. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis. , 2013, JAMA neurology.
[9] A. Oxenius,et al. Macrophage and T Cell Produced IL-10 Promotes Viral Chronicity , 2013, PLoS pathogens.
[10] Claude Gravel,et al. Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] P. Caroni,et al. Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival , 2013, Neuron.
[12] A. Planas,et al. IL-10 Deficiency Exacerbates the Brain Inflammatory Response to Permanent Ischemia without Preventing Resolution of the Lesion , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] Wim Robberecht,et al. The changing scene of amyotrophic lateral sclerosis , 2013, Nature Reviews Neuroscience.
[14] S. Powell,et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival , 2012, EMBO molecular medicine.
[15] P. Andersen,et al. Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. , 2012, Human molecular genetics.
[16] Sachiko Sato,et al. Galectin-3 Is Required for Resident Microglia Activation and Proliferation in Response to Ischemic Injury , 2012, The Journal of Neuroscience.
[17] P. Andersen,et al. Misfolded superoxide dismutase‐1 in CSF from amyotrophic lateral sclerosis patients , 2011, Journal of neurochemistry.
[18] J. Kriz,et al. Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice , 2011, Experimental Neurology.
[19] M. McGrath,et al. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS) , 2011, Journal of Neuroimmunology.
[20] Jeffery N Agar,et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS , 2010, Nature Neuroscience.
[21] D. Maysinger,et al. Lipopolysaccharide-QD micelles induce marked induction of TLR2 and lipid droplet accumulation in olfactory bulb microglia. , 2010, Molecular pharmaceutics.
[22] Margarida Saraiva,et al. The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.
[23] J. Julien,et al. Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury , 2010, Glia.
[24] Donald A. Wilson,et al. Olfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer's Disease Mouse Model , 2010, The Journal of Neuroscience.
[25] J. Julien,et al. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase , 2009, Experimental Neurology.
[26] Ruth R. Montgomery,et al. IL-10 Signaling Blockade Controls Murine West Nile Virus Infection , 2009, PLoS pathogens.
[27] Ruslan Medzhitov,et al. Transcriptional control of the inflammatory response , 2009, Nature Reviews Immunology.
[28] Weihua Zhao,et al. Microglia in ALS: The Good, The Bad, and The Resting , 2009, Journal of Neuroimmune Pharmacology.
[29] Konan Peck,et al. Identification and characterization of oligonucleotides that inhibit Toll‐like receptor 2‐associated immune responses , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] A Florence Keller,et al. Live imaging of amyotrophic lateral sclerosis pathogenesis: Disease onset is characterized by marked induction of GFAP in Schwann cells , 2009, Glia.
[31] Y. Weng,et al. Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation. , 2009, Brain : a journal of neurology.
[32] K. Fassbender,et al. Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2* , 2009, Journal of Biological Chemistry.
[33] A. Bagić,et al. Olfactory pathogenesis of idiopathic Parkinson disease revisited , 2008, Movement disorders : official journal of the Movement Disorder Society.
[34] E. Riley,et al. IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.
[35] Y. Weng,et al. Live Imaging of Neuroinflammation Reveals Sex and Estrogen Effects on Astrocyte Response to Ischemic Injury , 2008, Stroke.
[36] S. Appel,et al. Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia , 2007, Journal of neurochemistry.
[37] D. Sacks,et al. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. , 2007, Trends in immunology.
[38] D. Maysinger,et al. Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles. , 2007, Nano letters.
[39] Y. Yanagawa,et al. Enhanced IL-10 Production by TLR4- and TLR2-Primed Dendritic Cells upon TLR Restimulation1 , 2007, The Journal of Immunology.
[40] G. Gowing,et al. Selective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain , 2007, The Journal of Neuroscience.
[41] J. Julien,et al. Absence of Tumor Necrosis Factor-α Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations , 2006, The Journal of Neuroscience.
[42] S. Mckercher,et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.
[43] G. Kollias,et al. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.
[44] Lan Guo,et al. Development of rabbit monoclonal and polyclonal antibodies for detection of site-specific histone modifications and their application in analyzing overall modification levels , 2006, Cell Research.
[45] K. Asadullah,et al. Molecular mechanisms of interleukin‐10‐mediated inhibition of NF‐κB activity: a role for p50 , 2004, Clinical and experimental immunology.
[46] C. Franceschi,et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease , 2003, Genes and Immunity.
[47] Minh N. H. Nguyen,et al. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin‐1β in neurodegeneration , 2001, Annals of neurology.
[48] R. H. Brown,et al. A transgenic-mouse model of amyotrophic lateral sclerosis. , 1994, The New England journal of medicine.
[49] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[50] Jacob I. Ayers,et al. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] C. Caltagirone,et al. Effect of age on surface molecules and cytokine expression in human dendritic cells. , 2011, Cellular immunology.
[52] H. Shill,et al. Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders , 2008, Acta Neuropathologica.
[53] A. Sik,et al. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis , 2006, Nature Neuroscience.
[54] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[55] K. Wiktorowicz,et al. [Biological properties of interleukin 10]. , 1994, Postepy higieny i medycyny doswiadczalnej.